Sell at $9.00 this summer!
I agree with you because I see the balance sheet is very strong. After debt, the stock should be $13 today. I am scratching my head man.
You do exit while I am picking up as low as possible. This will pass.
Raymond James just said that this are beginning bidding numbers. The bid would be much higher than $28.00.
I would think $35 is possible.
If approval gets through, dilution is irrelevant because the stock price will be much higher and the SRPT will make a real revenue.
The secondary offering is good a signal of the drug approval.
It seems like the company insiders are confident that FDA would approve their drugs sooner or later.